Search Page

1

Cite

Share

A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model.

Ahn E, Kim H, Han KT, Sin JI. Ahn E, et al. Cancer Lett. 2015 Jan 28;356(2 Pt B):676-85. doi: 10.1016/j.canlet.2014.10.019. Epub 2014 Oct 22. Cancer Lett. 2015. PMID: 25449428

Cite

Share

2

Cite

Share

HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development.

Arab A, Yazdian-Robati R, Behravan J. Arab A, et al. Arch Immunol Ther Exp (Warsz). 2020 Jan 9;68(1):2. doi: 10.1007/s00005-019-00566-1. Arch Immunol Ther Exp (Warsz). 2020. PMID: 31915932 Free PMC article. Review.

Cite

Share

3

Cite

Share

Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.

Mendoza JM, Amante DH, Kichaev G, Knott CL, Kiosses WB, Smith TR, Sardesai NY, Broderick KE. Mendoza JM, et al. Vaccines (Basel). 2013 Aug 28;1(3):384-97. doi: 10.3390/vaccines1030384. Vaccines (Basel). 2013. PMID: 26344120 Free PMC article.

Cite

Share

4

Cite

Share

Adenovirus Type 6: Subtle Structural Distinctions from Adenovirus Type 5 Result in Essential Differences in Properties and Perspectives for Gene Therapy.

Romanenko M, Osipov I, Netesov SV, Davydova J. Romanenko M, et al. Pharmaceutics. 2021 Oct 8;13(10):1641. doi: 10.3390/pharmaceutics13101641. Pharmaceutics. 2021. PMID: 34683934 Free PMC article. Review.

Cite

Share

5

Cite

Share

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.

De Giovanni C, Landuzzi L, Palladini A, Ianzano ML, Nicoletti G, Ruzzi F, Amici A, Croci S, Nanni P, Lollini PL. De Giovanni C, et al. Cancers (Basel). 2019 Apr 11;11(4):517. doi: 10.3390/cancers11040517. Cancers (Basel). 2019. PMID: 30979001 Free PMC article.

Cite

Share

6

Cite

Share

Electroporation-enhanced delivery of nucleic acid vaccines.

Broderick KE, Humeau LM. Broderick KE, et al. Expert Rev Vaccines. 2015 Feb;14(2):195-204. doi: 10.1586/14760584.2015.990890. Epub 2014 Dec 9. Expert Rev Vaccines. 2015. PMID: 25487734 Review.

Cite

Share

7

Cite

Share

Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes.

McCann KJ, Mander A, Cazaly A, Chudley L, Stasakova J, Thirdborough S, King A, Lloyd-Evans P, Buxton E, Edwards C, Halford S, Bateman A, O'Callaghan A, Clive S, Anthoney A, Jodrell DI, Weinschenk T, Simon P, Sahin U, Thomas GJ, Stevenson FK, Ottensmeier CH. McCann KJ, et al. Clin Cancer Res. 2016 Oct 1;22(19):4827-4836. doi: 10.1158/1078-0432.CCR-15-2507. Epub 2016 Apr 18. Clin Cancer Res. 2016. PMID: 27091407 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy.

Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, van den Tol PM, Davalos RV, Rubinsky B, de Gruijl TD, Miklavčič D, Meijerink MR. Geboers B, et al. Radiology. 2020 May;295(2):254-272. doi: 10.1148/radiol.2020192190. Epub 2020 Mar 24. Radiology. 2020. PMID: 32208094 Review.

Cite

Share

9

Cite

Share

Fundamentals of Cancer Immunology and Their Application to Cancer Vaccines.

Bullock TNJ. Bullock TNJ. Clin Transl Sci. 2021 Jan;14(1):120-131. doi: 10.1111/cts.12856. Epub 2020 Oct 29. Clin Transl Sci. 2021. PMID: 32770735 Free PMC article.

Cite

Share

10

Cite

Share

Immunogenicity of a xenogeneic multi-epitope HER2⁺ breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205.

Gül A, Döşkaya M, Can H, Karakavuk M, Anıl-İnevi M, Sağlam-Metiner P, Atalay-Şahar E, Değirmenci-Döşkaya A, Zekioğlu O, Gürüz AY, Gülce-Iz S, Yeniay L. Gül A, et al. Vaccine. 2022 Apr 6;40(16):2409-2419. doi: 10.1016/j.vaccine.2022.03.014. Epub 2022 Mar 16. Vaccine. 2022. PMID: 35305824

Cite

Share